Regulatory Expertise Nor Consult combines academic rigor with regulatory acumen led by a former FDA reviewer, presenting a compelling value proposition for life sciences clients seeking regulatory strategy, submissions, and robust statistics to accelerate approvals.

Biometric Specialization Focused on biometric consulting across cardiovascular, cardiorenal, infectious disease, spine and device domains, offering end-to-end support from trial design to regulatory submission, ideal for companies advancing high-impact therapies and devices.

End-to-End Services Capability areas include statistical design and analysis, RWE generation, digital health integration, wearables, biomarkers, surrogate endpoints, and SAPs/CSRs, enabling clients to streamline development programs and improve submission readiness.

Global Collaboration Global partnerships and a lean team of seasoned experts position Nor Consult to support biotech startups and established pharma/medical device companies seeking agile Biometric and regulatory guidance across multiple markets.

Growth Readiness With revenue in the lower mid-range and a focused niche, there is an opportunity to upsell comprehensive regulatory strategy packages, post-approval pharmacovigilance, and expanded RWE offerings to broaden client engagements.